首页> 外文期刊>Kidney international. >Role of protein kinase pathways in IL-1-induced chemoattractant expression by human mesangial cells
【24h】

Role of protein kinase pathways in IL-1-induced chemoattractant expression by human mesangial cells

机译:蛋白激酶途径在人肾小球系膜细胞IL-1诱导的趋化因子表达中的作用

获取原文
获取外文期刊封面目录资料

摘要

Role of protein kinase pathways in IL-1-induced chemoattractant expression by human mesangial cells. Human mesangial cells produce the monocyte-specific chemotactic factor monocyte chemoattractant protein-1 (MCP-1) in response to a variety of stimuli, including the pro-inflammatory cytokine interleukin-1 (IL-1). The intracellular signals responsible for mediating the effects of IL-1 on MCP-1 expression in human mesangial cells have not been defined. Evidence from other types of cells suggests that protein kinases are involved in MCP-1 gene regulation. We investigated the role of protein kinase pathways in mediating IL-1-induced MCP-1 expression. Activation of protein kinase C (PKC) by phorbol esters or diacyglycerol up-regulated mesangial MCP-1 message and bioactivity in a fashion similar to IL-1. However, while inhibition of PKC activity completely blocked phorbol-induced MCP-1 up-regulation, induction by IL-1 was not prevented. Inhibitors of cyclic AMP (cAMP)-dependent protein kinase (PKA) also failed to block IL-1-induced MCP-1 expression. Furthermore, increasing intracellular cAMP and activating PKA attenuated basal MCP-1 mRNA levels by 82% and blocked IL-1 induced MCP-1 expression by 88%. Finally, the role of protein tyrosine kinases was studied. The structurally distinct protein tyrosine kinase (PTK) inhibitors genistein, herbimycin A, and tyrphostin each caused a dose-dependent inhibition of the effects of IL-1 on mesangial MCP-1 activity. IL-1 treatment of mesangial cells resulted in the up-regulation of three tyrosine phosphoproteins with apparent molecular masses between 40 and 62 kD. These results suggest that the effects of IL-1 on MCP-1 expression are not mediated through PKC or cAMP-PKA, but may be transduced through PTKs.
机译:蛋白激酶途径在人肾小球系膜细胞IL-1诱导的趋化表达中的作用。人肾小球系膜细胞响应多种刺激,包括促炎性细胞因子白介素-1(IL-1),产生单核细胞趋化因子单核细胞趋化蛋白-1(MCP-1)。尚未确定负责介导IL-1对人系膜细胞中MCP-1表达的影响的细胞内信号。其他类型细胞的证据表明,蛋白激酶参与了MCP-1基因的调控。我们调查了介导IL-1诱导的MCP-1表达的蛋白激酶途径的作用。佛波酯或双甘油对蛋白激酶C(PKC)的激活以类似于IL-1的方式上调了系膜MCP-1信息和生物活性。但是,虽然对PKC活性的抑制完全阻断了佛波醇诱导的MCP-1上调,但并未阻止IL-1的诱导。环状AMP(cAMP)依赖性蛋白激酶(PKA)的抑制剂也未能阻止IL-1诱导的MCP-1表达。此外,增加细胞内cAMP和激活PKA可使基础MCP-1 mRNA水平降低82%,并阻断IL-1诱导的MCP-1表达88%。最后,研究了蛋白质酪氨酸激酶的作用。结构上不同的蛋白酪氨酸激酶(PTK)抑制剂染料木黄酮,除草素A和酪氨酸磷酸酶各自引起IL-1对系膜MCP-1活性的剂量依赖性抑制。 IL-1处理肾小球系膜细胞导致三种酪氨酸磷酸化蛋白的上调,其表观分子量在40至62 kD之间。这些结果表明,IL-1对MCP-1表达的影响不是通过PKC或cAMP-PKA介导的,而是可以通过PTK进行转导的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号